personal scheduler Hamburg 2013 - Main Site Press Release 2013 Call for Abstracts General Information Programme Overview Letter from the President Keynote Lectures Main Sessions NEW - Free Paper Session Instructional Courses World Retina Day Retinal Detachment Course Uveitis Course Other Symposia Surgical Skills Training Courses
hamburg banner

Long-term effect of infliximab treatment for Bechet's uveitis

Session Details

Session Title: Uveitis & Intraocular Tumours

Session Date/Time: Friday 27/09/2013 | 14:30-16:00

Paper Time: 14:38

Venue: Hall C (Level 1)

First Author: K.Nakai JAPAN

Co Author(s):    K. Nishida              

Abstract Details

Purpose:

To evaluate the long-term effect of infliximab (IFX) for treating Bechet's uveitis.

Setting:

Retrospective review of 24 patients treated with IFX and followed 24 months (M).

Methods:

The inflammation was scored 0-3 6 M before and every 6 M after IFX. Patients were divided in two groups (one with long-term efficacy and the other with lost response), based on the score. The C-reactive protein (CRP) level was measured.

Results:

Seven patients had a lost response (scores: 6.3 before IFX; 1.4, 0-6 M after IFX; 2.1, 6-12 M; 2.7 12-18 M). Seventeen patients had long-term efficacy (scores: 3.8, 0.3, 0.1 and 0.1, respectively); the scores was significantly lower (P<.05) even before IFX, with no significant difference in CRP.

Conclusions:

Patients with high inflammation scores before IFX should be observed carefully.

Back to Freepaper Session
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy